Merck May Consider Selling Vioxx Again (Reuters)


Reuters - Merck & Co. Inc. will
consider selling its arthritis pill Vioxx again if the U.S.
Food and Drug Administration decides the cardiovascular risks
are similar to those of related prescription pain relievers, a
company official said on Thursday.

Read more...